Skip to content
Search

Latest Stories

NHS chief thanks Covid volunteers for supporting vaccination programme

The NHS England chief executive Amanda Pritchard saluted the effort of over 100,000 Covid volunteers who alongside the NHS staff helped to deliver record-breaking numbers of jabs in December.

The “selfless volunteers” devoted around two million hours to help ramp up the vaccination programme in 2021– with over nine million doses delivered since December 12, when the prime minister announced the turbo-charged vaccination drive.


NHS chief Amanda Pritchard Chief Executive of NHS England Amanda Pritchard (Photo by Tom Nicholson-WPA Pool/Getty Images)

Pritchard said: “Alongside NHS staff, our selfless volunteers have worked tirelessly to protect the nation – in football stadiums, shopping centres, Christmas markets and countless other vaccination sites up and down the country.

“I want to give my personal thanks to everyone who has given up their time to help us beat record after record – continuing to make the NHS Covid-19 vaccination programme the biggest and most successful in health service history.

“I’m sure the nation will join me in paying tribute to these amazing volunteers, whose efforts will undoubtedly help to save many more lives.”

In the wake of the Omicron variant, the NHS launched a drive to recruit more vaccinators and volunteers for which thousands came forward.

Besides, 17,500 people have expressed interest for paid vaccination role and 48,000 people have registered as steward volunteers through the NHS Volunteer Responders programme.

Pritchard continued to encourage people to take the booster jab  as the latest data from the UK Health Security Agency (UKHSA) showed two doses of a Covid vaccine are not sufficient to protect against Omicron.

More For You

Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less